Bard / Rochester Medical - 5954450 - Davol Ventralight St Elliptical
Ventralight ST meshVentralight ST mesh
Uncoated medium weight monofilament polypropylene mesh on the anterior side with an absorbable hydrogel barrier based on SepraTechnology on the posterior side for laparoscopic ventral hernia repair.
Healthcare Professional Downloads:
* Preclinical data on file at C. R. Bard. Results may not correlate to performance in humans.
** Based on a preclinical study of a composite polypropylene/ePTFE hernia repair mesh.
INDICATIONS
VentralightST Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias.
CONTRAINDICATIONS
- Do not use theVentralightST in infants or children whereby future growth will be compromised by use of such material.
- Do not useVentralightST Mesh for the reconstruction of cardiovascular defects.
- Literature reports there may be a possibility for adhesion formation when the polypropylene is placed in direct contact with the bowel or viscera.
WARNINGS
- Ensure proper orientation; the coated side of the prosthesis should be oriented against the bowel or sensitive organs. Do not place the polypropylene side against the bowel. There may be a possibility for adhesion formation when the polypropylene side is placed in direct contact with the bowel or viscera.
- If an infection develops, treat the infection aggressively. Consideration should be given regarding the need to remove the prosthesis. An unresolved infection may require removal of the prosthesis. Possible complications include seroma, adhesions, hematomas, inflammation, extrusion, fistula formation and recurrence of the hernia or soft tissue defect.
ADVERSE REACTIONS
Possible complications include seroma, adhesions, hematomas, inflammation, extrusion, fistula formation, infection, allergic reaction, and recurrence of the hernia or soft tissue defect.
Please consult package insert for more detailed safety information and instructions for use.
DAV/VLST/0917/0046(1)
Effective:
Minimal contraction shown in preclinical testing compared to a leading macroporous absorbable barrier mesh
At 4 weeks,VentralightST Mesh demonstrated 42% less area mesh contracture than a competitive macroporous absorbable barrier mesh. Results were statistically significant.*
Davol Ventralight St Elliptical 4.5
Manufacturer | Bard Rochester |
---|---|
Gender | Infants |
Code | 5954450 |
Sold By | Each |
UPC | - |
Warehouse | MultiWH |
Product Size | 4.5" |
Require Prescription? | Yes |
FSA | Yes |
WHSXX | GES |